Evolving ethics of COVID-19 challenge trials
- PMID: 32795408
- PMCID: PMC7831860
- DOI: 10.1016/S1473-3099(20)30649-6
Evolving ethics of COVID-19 challenge trials
Comment on
-
COVID-19 human challenge studies: ethical issues.Lancet Infect Dis. 2020 Aug;20(8):e198-e203. doi: 10.1016/S1473-3099(20)30438-2. Epub 2020 May 29. Lancet Infect Dis. 2020. PMID: 32479747 Free PMC article. Review.
References
-
- 1DaySooner Challenge trials for COVID-19, an open letter to Dr Francis Collins. July 15, 2020. https://1daysooner.org/openletter
-
- WHO Key criteria for the ethical acceptability of COVID-19 human challenge studies. May 6, 2020. https://www.who.int/ethics/publications/key-criteria-ethical-acceptabili... - PMC - PubMed
-
- WHO Advisory Group on Human Challenge Studies Feasibility, potential value and limitations of establishing a closely monitored challenge model of experimental COVID-19 infection and illness in healthy young adult volunteers. June 15, 2020. https://www.who.int/publications/m/item/feasibility-potential-value-and-...
-
- Broockman D, Kalla J, Guerrero A, et al. Broad cross-national public support for accelerated COVID-19 vaccine trial designs. OSF Preprints. 2020 doi: 10.31219/osf.io/au3fq. published online July 15. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
